Tag: Rostec

Rostec to Invest over 1 bln Rubles in Medical-Pharmaceutical Cluster in Yaroslavl Region

rostec
Ruselectronics Holding integrated with the state corporation Rostec will set up a medical pharmaceutical cluster in the Yaroslavl region under an agreement on cooperation with the Vega concern and the...

Rostec to Raise Money for Proton Beam Therapy Center Project

rostec
The state corporation Rostec is prepared to raise investment for the project to build a proton beam cancer therapy center in Novosibirsk. Shvabe Holding Deputy General Director Ivan Ozhgikhin earli...

Nacimbio and Lomonosov MSU to develop new immunobiological preparations

research
Pharmaceutical Holding State Corporation Rostec 'Nacimbio' and M.V. Lomonosov Moscow State University agreed on long-term cooperation in the development of innovative immunobiological drugs.

Sechenov University signs cooperation agreement with Shvabe and BARS Group

lab
Sechenov University has concluded cooperation agreement with Shvabe Holding and BARS Group (both companies are part of the Russia Rostec group).

Rostec will create unique oncology treatment center in Russian Far East

rostec
State Corporation Rostec and the administration of the Primorsky Krai, a federal subject in the Russian Far East, have signed an agreement to establish an oncology center of proton therapy.

There are no restrictions for development and production of medicines in Russia

manturov
The shares of imported and domestic drugs on the Russian pharmaceutical market should become equal by 2020.

Rostec plans to occupy at least 20% of the Russian ultrasound equipment market

ultrasound
A consortium of companies led by the Shvabe Holding of the Russian state-owned Rostec group will annually produce 2500 multifunctional ultrasound devices RUSCAN for selling to health facilities in Russia.

Output by NPO Biomed immunobiological products exceeded 6 million packages

biomed
NPO Biomed, the largest developer and manufacturer of immunobiological products in the Perm Krai, an affiliate of NPO Microgen of Nacimbio Holding Company, part of Rostec Corporation, marked its 120th anniversary.

Russian equipment for storage of thermolabile drugs was delivered to China

pozis
POZIS JSC, an affiliate of Techmash concern of Rostec Corporation, for the first time delivered Russian medical equipment to Hong Kong.

Nacimbio supplied more than 1 million doses of TBE vaccine

microgen
In January - May 2018, Nacimbio, a pharmaceutical holding company of Rostec Corporation, has supplied to all regions of Russia more than 1 million doses of vaccines for prevention of tick-borne encephalitis (TBE).

POZIS began to supply medical equipment to India

hospital
POZIS, a company that is part of Techmash concern of Rostec Corporation, for the first time shipped medical equipment to India. The company provided modern decontamination devices to one of the largest medical centers in Delhi.

Microgen increased its medicines output by 16%

microgen
NPO Microgen, a subsidiary of Nacimbio (part of Rostec Corporation), published its results for 2017. The company's revenue reached 7.7 billion rubles.

Russian government approved operation model for product labeling system

marking
Prime Minister of the Russian Federation signed the Order No. 791-r of April 28, 2018, which approved the operation model for the system of labeling products by means of identification in the Russian Federation.

Nacimbio was designated as vaccines supplier for National Vaccination Schedule

nacimbio
Nacimbio JSC, a pharmaceutical holding company of Rostec Corporation, received the status of sole supplier of immunobiological medicines used for vaccinations under the National Vaccination Schedule.

New product designed by Rostec will extend the life of donor organs

rostec
Techmash, a concern of Rostec Corporation, is building the first Russian complex of perfusion modules and devices for mobile systems of artificial blood circulation.

NPO Microgen launches a production area for botulinum toxins

microgen
NPO Microgen, a subsidiary of Nacimbio holding company of Rostec Corporation, is launching a new modern production area to manufacture Relatox, the only Russian botulinum toxin type A